N-0923 dopamine D2 receptor agonist: Phase II trials

Discovery Therapeutics Inc., Richmond, Va.
Product: N-0923 dopamine

Read the full 85 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE